Patents Issued in May 17, 2018
-
Publication number: 20180135062Abstract: The invention is directed to recombinant probiotic bacteria, especially for use in the treatment of an inflammatory skin dysfunction, as well as a method for treating an inflammatory skin dysfunction.Type: ApplicationFiled: November 2, 2015Publication date: May 17, 2018Inventors: Thomas Wirth, Juha Yrjänheikki, Haritha Samaranayake, Dirk Weber, Igor Mierau, Peter Allard Bron, Herwig Bachmann
-
Publication number: 20180135063Abstract: The present invention relates to excision of explant material comprising meristematic tissue from seeds, and storage of such material prior to subsequent use in plant tissue culture and genetic transformation. Methods for tissue preparation, storage, and transformation are disclosed, as is transformable meristem tissue produced by such methods, and apparati for tissue preparation.Type: ApplicationFiled: September 15, 2017Publication date: May 17, 2018Inventors: Beth Jo Calabotta, Kevin Lee Deppermann, Erik D. Dersch, Jerald D. Heise, Angela Ranae Koestel, Cindy L. Ludwig, Brian J. Martinell, Edward Williams
-
Publication number: 20180135064Abstract: Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.Type: ApplicationFiled: December 1, 2017Publication date: May 17, 2018Applicant: 22nd Century Limited, LLCInventors: Takashi HASHIMOTO, Akira Kato
-
Publication number: 20180135065Abstract: Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.Type: ApplicationFiled: December 1, 2017Publication date: May 17, 2018Applicant: 22nd Century Limited, LLCInventors: Takashi HASHIMOTO, Akira Kato
-
Publication number: 20180135066Abstract: The invention provides recombinant host organisms genetically modified with a polyunsaturated fatty acid (PUFA) synthase system and one or more accessory proteins that allow for and/or improve the production of PUFAs in the host organism. The present invention also relates to methods of making and using such organisms as well as products obtained from such organisms.Type: ApplicationFiled: July 26, 2012Publication date: May 17, 2018Applicants: DSM IP ASSETS B.V., DOW AGROSCIENCES LLCInventors: Terence A. Walsh, Daniel Gachotte, Ann Owens Merlo, Dayakar Reddy Pareddy, James Metz, Scott Bevan, Jerry Kuner
-
Publication number: 20180135067Abstract: In order to improve biomass productivity per unit area by extending the limit of high-density planting, the present invention produces plant biomass by cultivating, under a high-density planting condition, a plant body transformed with an exogenous gene which contains an MYB30-related gene.Type: ApplicationFiled: July 28, 2015Publication date: May 17, 2018Applicant: TOYOTA JIDOSHA KABUSHIKI KAISHAInventors: Kenichi OGAWA, Satoshi KONDO, Chikara OHTO, Soichiro NODA, Aya YASUKOCHI
-
Publication number: 20180135068Abstract: The present invention provides methods of identifying and producing dominant negative MSH1 genes in plants and methods of using plants comprising dominant negative MSH1 genes for Msh1 suppression.Type: ApplicationFiled: July 25, 2017Publication date: May 17, 2018Inventor: Michael E Fromm
-
Publication number: 20180135069Abstract: Provided are isolated polynucleotides which comprise a nucleic acid sequence at least 80% identical to SEQ ID NO: 321, 1-320, 322-480, 793-2945 or 2946; isolated polypeptides which comprise an amino acid sequence at least 80% homologous to SEQ ID NO: 517, 481-516, 518-792, 2947-4662 or 4663, nucleic acid constructs comprising same, transgenic cells and plants expressing same and methods of using same for increasing yield, biomass, growth rate, vigor, oil content, fiber yield, fiber quality, abiotic stress tolerance, and/or nitrogen use efficiency of a plant.Type: ApplicationFiled: January 3, 2018Publication date: May 17, 2018Applicant: Evogene Ltd.Inventors: Eyal EMMANUEL, Hagai KARCHI
-
Publication number: 20180135070Abstract: Described herein are plants that are resistant to herbicides, such as herbicide compositions comprising coronatine, where the herbicide-resistant plants express a modified CORONATINE INSENSITIVE 1 (COI1) protein.Type: ApplicationFiled: October 27, 2017Publication date: May 17, 2018Inventors: Sheng Yang He, Li Zhang, Jian Yao, Rahul Banerjee, John Withers
-
Publication number: 20180135071Abstract: The present invention relates to a plant, which is resistant to a pathogen of viral, bacterial, fungal or oomycete origin, wherein the plant has a reduced level, reduced activity or complete absence of DMR6 protein as compared to a plant that is not resistant to the said pathogen, in particular organisms of the Fungi or the phylum Oomycota. The invention further relates to a method for obtaining a plant, which is resistant to a pathogen of viral, bacterial, fungal or oomycete origin, comprising reducing the endogenous level or activity of DMR6 protein in the plant. In addition, the invention relates to the use of a DMR6 promotor for providing disease resistant plants.Type: ApplicationFiled: June 24, 2016Publication date: May 17, 2018Inventors: Mireille Maria Augusta VAN DAMME, Augustinus Franciscus Johannes Maria VAN DE ACKERVEKEN, Christianus Cornelis Nicolaas VAN SCHIE, Tieme ZEILMAKER
-
Publication number: 20180135072Abstract: This disclosure concerns nucleic acid molecules and methods of use thereof for control of hemipteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in hemipteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of hemipteran pests, and the plant cells and plants obtained thereby.Type: ApplicationFiled: May 23, 2016Publication date: May 17, 2018Inventors: Kenneth E. Narva, Elane Fishilevich, Meghan L. Frey, Murugesan Rangasamy, Sarah E. Worden, Premchand Gandra
-
Publication number: 20180135073Abstract: The present invention provides methods for modifying chromosomal sequences. In particular, methods are provided for using RNA-guided endonucleases or modified RNA-guided endonucleases to modify targeted chromosomal sequences.Type: ApplicationFiled: July 18, 2017Publication date: May 17, 2018Inventors: Fuqiang Chen, Gregory D. Davis
-
Publication number: 20180135074Abstract: Provided herein are recombinant AAV (rAAV) particles comprising a nucleic acid vector comprising a parvovirus B 19p6 promoter operatively linked to a heterologous gene, such as a human globin gene, and rAAV capsid proteins comprising one or more amino acid substitutions in a surface exposed loop of the capsid protein that result, e.g., in increased P antigen binding compared to a corresponding un-mutated AAV capsid protein. Also provided are methods and compositions related to such capsid proteins, methods of targeting gene expression to a cell of erythroid lineage, methods of treating a hemoglobinopathy using such rAAV particles, and methods for efficient transduction of a host cell suspension with a rAAV.Type: ApplicationFiled: February 19, 2016Publication date: May 17, 2018Applicant: University of Florida Research Foundation, IncorporatedInventors: Arun Srivastava, Chen Ling, Mavis Agbandje-McKenna
-
Publication number: 20180135075Abstract: The invention provides recombinant adenovirus (rAd) and rAd vectors comprising a bidirectional mouse CMV (mCMV) promoter operably linked to a first transgene in one direction and to a second transgene in the opposite direction. The invention also provides methods of making and using such rAd and rAd vectors.Type: ApplicationFiled: April 12, 2016Publication date: May 17, 2018Inventors: Kerstin WUNDERLICH, Jerôme H.H.V. CUSTERS, Jort VELLINGA, Barbara Petronella SANDERS
-
Publication number: 20180135076Abstract: Disclosed herein is a recombinant adeno-associated virus (AAV) vector comprising (a) a variant AAV2 capsid protein, wherein the variant AAV2 capsid protein comprises at least four amino acid substitutions with respect to a wild type AAV2 capsid protein; wherein the at least four amino acid substitutions are present at the following positions in an AAV2 capsid protein sequence: 457, 492, 499 and 533; and (b) a heterologous nucleic acid comprising a nucleotide sequence encoding a gene product.Type: ApplicationFiled: February 17, 2015Publication date: May 17, 2018Inventor: Ralph Michael Linden
-
Publication number: 20180135077Abstract: A lentiviral vector production system comprises (a) a lentiviral culture supplement to control cell growth, (b) a transfection reagent comprising DHDMS, DOPE, and cholesterol to increase transfection efficiency, (c) a lentiviral production enhancer comprising sodium propionate, sodium butyrate, and caffeine to boost lentiviral production, wherein the lentiviral vector production system is serum-free. A method of lentiviral vector production comprises using the lentiviral production system. Another method for lentiviral vector production comprises (a) culturing eukaryotic cells in a serum-free medium, (b) providing a lentiviral culture supplement to control cell growth, (c) transfecting the cells with a lentiviral vector using a transfection reagent comprising DHDMS, DOPE, and cholesterol to increase transfection efficiency, and (d) providing a lentiviral production using a lentiviral production enhancer comprising sodium propionate, sodium butyrate capable of boosting lentiviral production.Type: ApplicationFiled: September 29, 2017Publication date: May 17, 2018Inventors: Xin YU, Xavier de MOLLERAT du JEU
-
Publication number: 20180135078Abstract: The present invention relates to gene therapy for treatment or prevention of choroideremia.Type: ApplicationFiled: October 31, 2017Publication date: May 17, 2018Inventors: Robert MACLAREN, Miguel SEABRA, Matthew John DURING
-
Publication number: 20180135079Abstract: Polysaccharide nanoparticles that are particularly useful in for example drug and agent delivery, tissue-specific targeting, for medical imaging and diagnosis, as well as modifiers of physico-chemical properties. The nanoparticles can be highly-branched glucose homopolymers and can be characterized by a uniform spherical shape. They are monodisperse, hydrophilic and produce low solution viscosities. The nanoparticles are non-toxic, biocompatible and biodegradable. Also, the process of isolation of said polysaccharide nanoparticles from various organisms including, but not limited to, microorganisms such as bacteria and yeasts. Also provided are methods for chemical conjugation of the polysaccharide nanoparticles with various agents. Also provided are examples of use of the polysaccharide nanoparticles and their derivatives as drug delivery systems and fluorescent diagnostics.Type: ApplicationFiled: November 17, 2017Publication date: May 17, 2018Inventors: John Robert DUTCHER, Terry J. BEVERIDGE, Anton KORENEVSKI, Oleg STUKALOV, Erzsebet PAPP-SZABO
-
Publication number: 20180135080Abstract: Methods for detecting and characterizing large genomic rearrangements induced by modified nucleases at high resolution and for quantifying the frequency of the large genomic or gene rearrangements induced by modified nucleases using Molecular Combing.Type: ApplicationFiled: November 15, 2017Publication date: May 17, 2018Applicant: GENOMIC VISION SAInventors: Sebastien Barradeau, Aaron Bensimon, Laurent Cavarec
-
Publication number: 20180135081Abstract: The present invention relates to methods for producing oxygenated terpenoids. Polynucleotides, derivative enzymes, and host cells for use in such methods are also provided.Type: ApplicationFiled: August 21, 2015Publication date: May 17, 2018Inventors: Ajikumar Parayil Kumaran, Chin Giaw Lim, Liwei Li, Souvik Ghosh, Christopher Pirie, Anthony Qualley
-
Publication number: 20180135082Abstract: Disclosed are methods and engineered microorganisms that enhance or improve the production of crotyl alcohol. The engineered microorganisms include genetic modifications in alcohol dehydrogenase, alkene reductase or both enzymatic activities. By such genetic modifications, a crotyl alcohol production pathway is provided or improved.Type: ApplicationFiled: April 7, 2016Publication date: May 17, 2018Applicant: GENOMATICA, iNC.Inventors: Stephanie J. Culler, Nicholas Eakley, Kevin Gregory Hoff, Robin E. Osterhout, Priti Pharkya, Erik C. Ralph, Stephen Van Dien
-
Publication number: 20180135083Abstract: The present invention relates to a method of forming dihydroferulic acid comprising providing ferulic acid and incubating the ferulic acid with a bacterial preparation of Lactobacillus johnsonii CNCM 1-1225 or a bacterial preparation of natural derivatives of Lactobacillus johnsonii CNCM 1-1225. An aspect of the invention is a composition comprising dihydroferulic acid and a bacterial preparation of Lactobacillus johnsonii CNCM 1-1225 or its natural derivatives. A further aspect of the invention is a composition comprising ferulic acid and a bacterial preparation of Lactobacillus johnsonii CNCM 1-1225 or its natural derivatives for use in the treatment or prevention of metabolic disease. Further aspects of the invention are the use of a bacterial preparation of Lactobacillus johnsonii CNCM 1-1225 or its natural derivatives; and a kit for preparing a food product.Type: ApplicationFiled: March 24, 2016Publication date: May 17, 2018Inventors: Rachid Bel-Rhlid, Kaori Minehira Castelli, Stephane Duboux, Laure Poquet
-
Publication number: 20180135084Abstract: A method of producing a lipid, containing the steps of: culturing a transformant obtained by introducing a gene encoding the following protein (a) or (b) into cyanobacteria, and producing a lipid: (a) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 1; and (b) a protein consisting of an amino acid sequence having 60% or more identity with the amino acid sequence of the protein (a), and having ?-ketoacyl-ACP synthase activity.Type: ApplicationFiled: May 20, 2016Publication date: May 17, 2018Applicant: Kao CorporationInventors: Akihito KAWAHARA, Shinji SUGIHARA
-
Publication number: 20180135085Abstract: The present invention relates to a method of producing at least one amino acid from a carbon source in aerobic conditions, the method comprising: (a)step of producing ethanol and/or acetate from the carbon source in aerobic conditions, comprising (i)contacting a reaction mixture comprising—a first acetogenic microorganism in an exponential growth phase; —free oxygen; and —a second acetogenic microorganism in a stationary phase wherein the first and second acetogenic microorganism is capable of converting the carbon source to the acetate and/or ethanol; and (b)step of contacting the acetate and/or ethanol from step (a) with a third microorganism capable of converting the acetate and/or ethanol to at least one amino acid.Type: ApplicationFiled: June 21, 2016Publication date: May 17, 2018Applicant: EVONIK DEGUSSA GMBHInventors: Thomas HAAS, Simon BECK, Thomas BÜLTER, Anja HECKER née THIESSENHUSEN, Martin DEMLER
-
Publication number: 20180135086Abstract: The present disclosure relates to a protein having the activity of exporting O-acetylhomoserine and a novel modified protein thereof, a microorganism capable of producing O-acetylhomoserine with enhanced expression of the protein, and a method for producing O-acetylhomoserine using the microorganism.Type: ApplicationFiled: June 3, 2016Publication date: May 17, 2018Inventors: Jee Yeon BAE, Ji Hyun SHIM, Hyun Ah KIM, Juhee SEO, Yong Uk SHIN, Jae Hee LEE, Sang Kyoum KIM, So Young KIM
-
Publication number: 20180135087Abstract: The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.Type: ApplicationFiled: June 27, 2017Publication date: May 17, 2018Inventors: Anthony P. BURGARD, Robin E. OSTERHOUT, Priti PHARKYA, Mark J. BURK
-
Publication number: 20180135088Abstract: Provided is a method for industrially mass-producing a modified xylopolysaccharide from biomass. The biomass used as a raw material includes xylan in plant cell walls, having at least one kind of substituents selected from acetyl, feruloyl arabinofuranosyl and coumaroyl arabinofuranosyl groups in the side chains of xylan. A passage controlling mechanism is internally arranged to generate plug-flow onto a slurry containing the biomass at a solid content in 10 mass % to 30 mass %. The hydrothermal treatment is performed under the controlled conditions: at a temperature of 160° C. or more, at a pressure equal to or higher than the saturated water vapor pressure at said temperature, and with a reaction severity R0 ranging from 3000 to 7000. A modified xylopolysaccharide is obtained as preserving the substituents in the side chains of xylan by performing a continuous hydrothermal treatment in a cylindrical plug-flow reactor.Type: ApplicationFiled: March 28, 2016Publication date: May 17, 2018Inventors: Satoshi MAKISHIMA, Hirofumi IKEDA, Yousuke YAMAKAWA, Yoshihiko AMANO, Nobuaki SATO, Tsutomu ARAI
-
Publication number: 20180135089Abstract: The present invention relates to a method for chondroitin sulfate biosynthesis, belongs to the field of pharmaceuticals field. CS was biosynthesized by sulfating the chondroitin with C4ST or C6ST in Tris-HCI buffer assisted with 3?-phosphoadenosine 5?-phophosulfate (PAPS). C4ST and C46ST came from bioengineered Escherichia coli or Pichia pastoris. Chondroitin came from bioengineered Bacillus subtilis 168.Type: ApplicationFiled: November 10, 2017Publication date: May 17, 2018Inventors: Zhen Kang, Jian Chen, Guocheng Du, Zhengxiong Zhou
-
Publication number: 20180135090Abstract: Disclosed herein are methods of manufacturing therapeutic proteins.Type: ApplicationFiled: April 27, 2016Publication date: May 17, 2018Inventors: Rasheed TIJANI, Darryl Bacon SAMPEY, John ROBBLEE, Gan WEI, Chaomei HE
-
Publication number: 20180135091Abstract: The present invention pertains to the field of cell cultivation. Small scale cell culture systems are provided which simulate large scale perfusion cultures of suspension cells. The present invention in particular provides methods for cultivating cells wherein cell sedimentation is used to separate cells from culture medium for replacing part of the culture medium.Type: ApplicationFiled: May 25, 2016Publication date: May 17, 2018Inventors: Steffen GOLETZ, Rainer STAHN, Steffen KREYE
-
Publication number: 20180135092Abstract: An isolated nucleic acid encoding a leader, which has a specific sequence, an isolated leader peptide encoded by such nucleic acid, an expression cassette comprising such nucleic acid encoding a leader operably linked to a nucleic acid sequence encoding a POI, a recombinant yeast host cell or a vector comprising such expression cassette, a method of producing a POI in such yeast host cell, and further the use of the specific nucleic acid for the secretion of a POI from a host cell and/or to increase the secretion of a POI from a host cell.Type: ApplicationFiled: January 2, 2018Publication date: May 17, 2018Inventors: Brigitte Gasser, Diethard Mattanovich, Silvia Heiss
-
Publication number: 20180135093Abstract: A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed. The system is designed to dynamically adjust motor idle torque to control heat load and employs a fast focus process for determining the true focus position of an individual microorganism. The system also may quantify the relative abundance of viable microorganisms in a sample using dynamic dilution, and facilitate growth of microorganisms in customized media for rapid, accurate antimicrobial susceptibility testing.Type: ApplicationFiled: December 20, 2017Publication date: May 17, 2018Applicant: Accelerate Diagnostics, Inc.Inventors: Austin Ashby, Wayne Showalter, Jasmin Cote
-
Publication number: 20180135094Abstract: An improved method and related apparatus for detecting bacteria viability and drug effects using metabolic monitoring. A fluorescent material which is quenched by oxygen is co-localized with the target bacteria, and fluorescence signal is detected at the co-localized places. In some embodiments, the fluorescent material is a fluorescent nanoparticle mixed with the target bacteria in the sample, and co-localization is enhanced using centrifugation, electrophoresis, microflow path modified with antibodies, magnetic force, etc. In some other embodiments, the fluorescent material is a fluorescent film or 3-D matrix immobilized in the bacterial culture chamber, and bacteria in the sample is gathered into localized regions of the bacteria culture chamber where the fluorescent film or 3-D matrix is present by ways of centrifugation, electrophoresis or microflow path. Plasmonic nanoparticles with a metal core and plasmonic film with a metal film may be used as the fluorescent nanoparticles and fluorescent film.Type: ApplicationFiled: June 20, 2016Publication date: May 17, 2018Applicant: Konica Minolta Laboratory U.S.A., Inc.Inventor: Noriaki YAMAMOTO
-
Publication number: 20180135095Abstract: Compositions and methods for isolating polypeptides having antibiotic activity are provided. In some aspects, bacterial cell populations are provided that express a surface-displayed library of candidate polypeptide sequences under the control of an inducible promoter.Type: ApplicationFiled: April 29, 2016Publication date: May 17, 2018Inventors: Bryan William DAVIES, Ashley Timberlake TUCKER, M. Stephen TRENT
-
Publication number: 20180135096Abstract: Method for isolating microorganism from a sample likely contaminated by microorganism, including: (a) device for isolating microorganisms including a bottom waterproof layer, a nutritional layer, which is placed on the bottom layer and includes a dehydrated culture medium, an isolation layer which is pervious to elements included in the nutritional layer and is capable of retaining the bacteria on the surface and covering all or part of the nutritional layer, and a top protective layer; (b) depositing a volume of the sample on the isolation layer; (c) isolating the microorganisms by impoverishing or layering the sample using an isolating device; (d) incubating the device for an amount of time at a temperature to enable growth of microorganisms, method including at least one step of rehydrating the culture medium using a volume of liquid before or with step b) and/or c) and/or d), before or simultaneously with step b) and/or c).Type: ApplicationFiled: January 11, 2018Publication date: May 17, 2018Applicant: BIOMÉRIEUXInventors: Jean-Pierre FLANDROIS, Bernard LIMON, Christine ROZAND, Marie-Pierre MONTET
-
Publication number: 20180135097Abstract: Methods for measuring REP-1 and REP-2 activity are provided. In certain embodiments, a method includes: (a) contacting cells that do not express endogenous functional REP-1 or REP-2 protein with an adeno-associated viral (AAV) vector comprising a CHM gene encoding a REP-1 protein or CHM like gene encoding a REP-2 protein under conditions allowing cell transduction; (b) incubating transduced cells under conditions allowing expression of the encoded REP-1 or REP-2 protein; (c) lysing the transduced cells to produce an extract comprising the encoded REP-1 or REP-2 protein and Rab small GTPase (Rabs); (d) incubating said extract with a Rab substrate for a period of time and under conditions allowing prenylation of the Rab thereby forming prenylated Rab; and (e) detecting and/or quantifying the prenylated Rab, wherein the amount of prenylated Rab reflects REP-1 or REP-2 activity thereby measuring REP-1 or REP-2 activity.Type: ApplicationFiled: November 7, 2017Publication date: May 17, 2018Applicant: Spark Therapeutics, Inc.Inventors: John Fraser WRIGHT, Marina SUMAROKA
-
Publication number: 20180135098Abstract: A diabetes test system for measuring blood glucose levels is provided, which includes a glucose meter, at least one diabetic test strip, and a container or pouch for storing the diabetes test strips and protecting them during transport. Methods of packaging diabetes test strips are also provided. The glucose meter includes software for detecting the validity of the at least one diabetic test strip, and a communication device that transmits data relating to the blood glucose level of the user to an external device. A secure packaging system for diabetes test strips which eliminates gray market sales of such test strips is also provided.Type: ApplicationFiled: February 1, 2017Publication date: May 17, 2018Inventor: Samuel Messinger
-
Publication number: 20180135099Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to coded, labeled probes that are capable of binding to and identifying target molecules based on the probes' label codes. Methods of making and using such probes are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.Type: ApplicationFiled: January 2, 2018Publication date: May 17, 2018Inventors: Gary K. GEISS, Sean M. FERREE, Philippa Jane WEBSTER, Krassen M. DIMITROV
-
Publication number: 20180135100Abstract: Methods, devices, systems and compositions for detecting nucleic acids in polymerase chain reaction assays, such as droplet digital polymerase chain reaction (ddPCR) assays, using intercalating dyes. A dual surfactant system with at least one fluorosurfactant and at least one non-ionic non-fluorosurfactant may be employed for droplet generation and nucleic acid detection.Type: ApplicationFiled: November 20, 2017Publication date: May 17, 2018Inventors: Adam Lowe, Geoff McDermott, Christopher M. Hindson, Erin R. Chia, Amy L. Hiddessen, Benjamin J. Hindson, Chunxiao Han, Yaqi Wang
-
Publication number: 20180135101Abstract: Method and sample vessels are provided for amplification and sequencing of nucleic acids in a sample.Type: ApplicationFiled: June 2, 2016Publication date: May 17, 2018Inventors: Mark Aaron Portiz, Kirk Max Ririe, Christopher Paul Pasko, Ann Michelle Demogines, Robert John Crisp, Margarita Rogatcheva, Robert Cornelius Trauscht, Matthew Kam Jones, Tyler Lane Healy
-
Publication number: 20180135102Abstract: Systems and methods for performing simultaneous nucleic acid amplification and detection. The systems and methods comprise methods for managing a plurality of protocols in conjunction with directing a sensor array across each of a plurality of reaction chambers. In certain embodiments, the protocols comprise thermocycling profiles and the methods may introduce offsets and duration extensions into the thermocycling profiles to achieve more efficient detection behavior.Type: ApplicationFiled: September 15, 2017Publication date: May 17, 2018Inventors: Thomas Catalino Gubatayao, Kalyan Handique, Karthik Ganesan, Daniel M. Drummond
-
Publication number: 20180135103Abstract: The present disclosure relates to methods for determining the amount or concentration of a nucleic acid of interest in an unprocessed sample by analyzing a processed sample and a reference sample with digital polymerase chain reaction (dPCR).Type: ApplicationFiled: September 21, 2017Publication date: May 17, 2018Applicant: Roche Molecular System, Inc.Inventors: Alan Furlan, Michael Zeder
-
Publication number: 20180135104Abstract: The present invention provides methods, reagents and kits for carrying out a variety of assays suitable for analyzing polynucleotides or samples that include an amplification step performed in a multiplex fashion. Also provided are methods for analyzing and improving the efficiency of amplification and for carrying out gene expression analysis.Type: ApplicationFiled: October 17, 2017Publication date: May 17, 2018Inventors: Mark Andersen, David Ruff
-
Publication number: 20180135105Abstract: Provided herein is technology relating to isolating nucleic acids. In particular, the technology relates to methods and kits for extracting nucleic acids from problematic samples such as stool.Type: ApplicationFiled: November 9, 2017Publication date: May 17, 2018Inventors: Janelle J. Bruinsma, Michael J. Domanico, Graham P. Lidgard, Hongzhi Zou, William G. Weisburg, Hemanth D. Shenoi, James P. Light, II, Keith Kopitzke, John Zeis
-
Publication number: 20180135106Abstract: The present invention provides miniaturized instruments for conducting chemical reactions where control of the reaction temperature is desired or required. Specifically, this invention provides chips and optical systems for performing and monitoring temperature-dependent chemical reactions. The apparatus and methods embodied in the present invention are particularly useful for high-throughput and low-cost amplification of nucleic acids.Type: ApplicationFiled: January 12, 2018Publication date: May 17, 2018Inventors: Victor Joseph, Amjad Huda, Alnoor Shivji, Jie Zhou
-
Publication number: 20180135107Abstract: The present invention provides miniaturized instruments for conducting chemical reactions where control of the reaction temperature is desired or required. Specifically, this invention provides chips and optical systems for performing and monitoring temperature-dependent chemical reactions. The apparatus and methods embodied in the present invention are particularly useful for high-throughput and low-cost amplification of nucleic acids.Type: ApplicationFiled: January 12, 2018Publication date: May 17, 2018Inventors: Victor Joseph, Amjad Huda, Alnoor Shivji, Jie Zhou
-
Publication number: 20180135108Abstract: This disclosure provides a method for detecting bacterial and fungal pathogens at clinically relevant concentrations in a clinical fluid sample using a visual color change test. The method includes the steps of: preparing the clinical fluid sample for heat lysing with water; heat lysing the clinical fluid sample to form a lysate that includes DNA and RNA forming a first mixture; mixing the lysate with a target primer set, EBT dye, a polymerase enzyme, and a chemical reaction buffer in a vial to form a reaction mixture; incubating the reaction mixture; amplifying the optional DNA and RNA and the target primer in the reaction mixture using LAMP; cooling the reaction mixture for a predetermined amount of time stopping the amplification; and identifying a color change in the reaction mixture that is indicative of the presence of bacterial or fungal pathogens.Type: ApplicationFiled: November 22, 2017Publication date: May 17, 2018Inventor: Brett Eric Etchebarne
-
Publication number: 20180135109Abstract: Disclosed herein are methods for evaluation, selection, optimization, and design of Cas9 molecule/gRNA molecule complexes.Type: ApplicationFiled: April 25, 2016Publication date: May 17, 2018Inventors: Hariharan JAYARAM, William SELLECK, JR.
-
Publication number: 20180135110Abstract: Devices for detecting targets in a sample and methods for detecting such targets are discussed. The targets may be biomarkers associated with a disease or other health condition. The devices may contain a disc including a plurality of microfluidic channels each extending in a radial direction of the disc, the microfluidic channels containing a plurality of capture molecules specific to at least one target. The capture molecules may include an aptamer and/or an oligonucleotide capable of hybridizing to the target. The methods may include introducing a fluid sample into one or more microfluidic channels of a disc, rotating the disc, such that the fluid sample flows radially outward through the microfluidic channel(s) to combine with capture molecules in the disc, and detecting a signal from the disc indicative of a presence of the target.Type: ApplicationFiled: December 5, 2017Publication date: May 17, 2018Applicant: POC MEDICAL SYSTEMS INCInventors: Sanjeev Saxena, Louis Eugene Burton, Andrea Cuppoletti
-
Publication number: 20180135111Abstract: The present invention relates to a method and an apparatus for ultrasensitive quantitative analysis of a DNA biomarker, and more particularly, provides a method and a kit for quantitative analysis of target DNA using an atomic force microscope. The DNA quantification according to the present invention enables the quantification of target DNA at low concentration, which has been difficult to carry out by a conventional method, through adhesion force mapping by using an atomic force microscope, and does not result in DNA amplification and transformation nor require the use of a fluorescent marker. In particular, the method applies the size optimization of a probe DNA spot generated to capture target DNA, thereby enabling the quantitative analysis of ten or less target DNA molecules on various substrates.Type: ApplicationFiled: June 28, 2017Publication date: May 17, 2018Inventors: Joon Won Park, Yoonhee Lee, Youngkyu Kim, Donggyu Lee